Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Bharat Parenterals Ltd

Bharat Parenterals Ltd share price and stock overview

Bharat Parenterals Ltd (NSE: BPLPHARMA, BSE: 541096) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE365Y01019 and a face value of Rs 10. As of 27 September 2026, it trades at Rs (1,898.00) with a market capitalisation of Rs 1306.1 crore. Figures are live and subject to change.

Bharat Parenterals Ltd

Pharmaceuticals - Indian - Formulations
NSE BSE
1,898.00 316.30 (20.00%) upARrowC
As on: 27-Sep-2026 , 05:24 PM
Market Cap(₹Cr) 1306.1
Book Value(₹Cr) 583.7857269
BSE Code : 541096 NSE Symbol : BPLPHARMA EPS(TTM) : 14.04 ISIN Demat : INE365Y01019 P/E(TTM) : 134.98 Face Value(₹) : 10 Div & Yield % : 0.05

Today Market

Stock Performance

Today Market

Today's High

73,968.05

Todday's Low

73,477.77

Open at

73,525.92

Previous Close

73,580.54

Volumes

Avg Price

315.20

Historical Performance

News

24 Sep 26
Bharat Parenterals closes equity trading window ahead of financial results declaration
Bharat Parenterals Limited informed the BSE Limited that the trading window for dealing in the company's equity shares will be closed from October 1, 2026, until 48 hours after the declaration of unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026.
24 Sep 26
Bharat Parenterals to consider preferential share issuance at board meeting on September 29
Bharat Parenterals Limited will hold a board meeting on Tuesday, September 29, 2026, to consider and evaluate a proposal for the issuance of equity shares or other eligible securities via a preferential issue, according to a regulatory filing with the BSE Limited.
27 Aug 26
Bharat Parenterals Limited sets record date for FY26 dividend approval in 2026
Bharat Parenterals Limited has set Saturday, September 12, 2026, as the record date for determining entitlement to receive a dividend for the financial year 2025-26, subject to approval by members at the annual general meeting scheduled for 2026.
05 Aug 26
Bharat Parenterals' board re-appointed Hemang Shah as Executive Director for five years
Bharat Parenterals Limited informed the BSE Limited that its board of directors approved the re-appointment of Mr.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
25-09-26 1578.90 1898.00 1570.10 1898.00 35202 2342 64058586.80 23140.50
24-09-26 1539.90 1590.20 1539.90 1581.70 2856 307 4473554.10 23063.10
23-09-26 1549.80 1560.30 1511.00 1545.50 2199 167 3403268.80 23446.80
22-09-26 1560.00 1560.00 1531.00 1531.70 1688 149 2613195.90 23329.00
21-09-26 1521.00 1560.20 1516.00 1541.70 902 145 1397414.90 23414.30
18-09-26 1541.20 1564.00 1499.90 1509.70 843 141 1292749.20 23346.40
17-09-26 1549.20 1549.20 1504.90 1534.00 32 12 48563.40 23270.60
16-09-26 1570.00 1570.00 1500.00 1509.80 515 86 783283.90 23217.60
15-09-26 1575.00 1575.00 1510.00 1543.40 2207 202 3398148.70 23118.60
11-09-26 1558.60 1577.00 1449.80 1505.10 8418 619 12593508.90 23398.10
123

Fundamentals

Company Valuation

Market Cap (₹cr)

1306.1

PE Ratio

134.98

PB Ratio

3.25

Dividend Yield

0.05

ROE

4.06

ROCE

5.74

Book Value (₹)

583.7857269

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 2750053 39.90 2750053 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1881598 27.30 1881598 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4631651 67.20 4631651 9
Total ShareHolding for Promoter & Group 4631651 67.20 4631651 9
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7500 0.11 7500 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 94180 1.37 94180 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102180 1.48 101680 5
plus  Non Institution
Bodies Corporate 567311 8.23 221781 43
Clearing Members 0 0.00 0 0
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 254998 3.70 248498 51
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 57513 0.83 54313 86
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 350994 5.09 350994 5
Individuals holding nominal share capital up to Rs. 1 lakh 926565 13.44 748040 2859
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 751 0.01 751 1
Others 0 0.00 0 0
Sub Total 2158132 31.31 1624377 3045
Total Public Shareholding 2260312 32.80 1726057 3050
Total of Promoter & Public ShareHolding 6891963 100.00 6357708 3059
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 6891963 100.00 6357708 3059

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales345.43340.38261.22217.98212.01
OPM (%)-6.20-9.977.1710.8013.15
OP-21.42-33.9518.7223.5527.88
Other Income9.5411.624.6811.747.78
PBIDT25.3614.3231.7631.6235.43
INTEREST12.5312.954.022.190.89
PBDT12.831.3727.7429.4334.54
PBT-21.42-33.9518.7223.5527.88
EO0.000.000.000.000.00
PBT after EO-21.42-33.9518.7223.5527.88
TAXES5.889.728.217.837.06
PAT-8.19-12.6314.5216.4421.05
EPS-39.62-66.6424.9428.4036.67
Raw Material49.0056.5166.2967.0162.60
Power and Fuel3.754.481.801.721.51
Employee Cost19.4814.598.728.267.25
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses8.0812.9011.1510.866.54
Miscellaneous Expenses3.703.882.262.343.97
Revenue (Growth %) 1.4830.3119.832.813.60
PBIDT (Growth %)77.10-54.910.45-10.775.61
PAT (Growth %) -35.15-186.98-11.70-21.913.25
PBIDT (Margin %)7.344.2112.1614.5016.71
PAT (Margin %) -2.37-3.715.567.549.93

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 6.896.895.825.775.775.73
Reserves Total 395.45379.93207.79185.29160.38138.21
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds402.34386.82213.61191.06166.15143.94
Secured Loans 20.0764.7483.0242.9112.5312.24
Unsecured Loans 0.000.000.002.802.480.00
Total Debt20.0764.7483.0245.7115.0112.24
Other Liabilities2.092.702.881.330.940.64
Total Liabilities424.50454.26299.51238.10182.10156.82
APPLICATION OF FUNDS :
Gross Block 97.9886.5783.4075.6274.4872.55
Less : Accumulated Depreciation 47.4440.3944.0439.3633.6427.99
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 50.5446.1839.3636.2640.8444.56
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress5.525.000.000.000.620.00
Producing Properties0.000.000.000.000.000.00
Investments 194.60167.8048.6138.4016.3041.82
Current Assets, Loans & Advances
Inventories 54.3346.8554.4337.8420.7622.43
Sundry Debtors 120.57164.73139.78112.4073.4067.83
Cash and Bank Balance7.3927.785.097.434.612.16
Loans and Advances 36.9726.4321.0116.8433.1112.81
Total Current Assets219.26265.78220.31174.51131.88105.23
Less : Current Liabilities and Provisions
Current Liabilities 94.8994.4187.4267.9132.9736.60
Provisions 0.560.510.211.611.990.84
Total Current Liabilities & Provisions95.4594.9287.6469.5234.9537.44
Net Current Assets123.81170.86132.68104.9996.9367.79
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets2.561.761.451.030.820.29
Deferred Tax Liability0.670.951.341.431.782.26
Net Deferred Tax1.890.810.11-0.40-0.96-1.97
Other Assets48.1463.6278.7658.8528.374.63
Total Assets424.50454.27299.52238.10182.10156.83
Contingent Liabilities61.0250.9122.3426.6922.7831.45

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 2.2428.5233.5169.25-48.80
Investing Activities 21.76-13.95-38.19-89.694.14
Net Cash Flow 1.933.01-4.84-1.21-0.10
Operating Activities -22.08-11.56-0.1619.2244.57

Peers

Balance Sheet Financial Ratios Profit & Loss
Accretion Nutrav...

Adline Chem Lab ...

Ajanta Pharma Lt...

3,547.80

(+0.23%)
Amrutanjan Healt...

506.35

(-0.75%)
Bafna Pharmaceut...

350.05

(+2.00%)
BDH Industries L...

Bharat Immunolog...

Bio Medica Labor...

164.50

(-2.37%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
BKR
Bharat Kumar R Desai
Chairman / Executive Director / M D / Promoter
Executive
Functional Directors
HJS
Hemang Jayendrabhai Shah
Executive Director
Exec.
Independent Directors
SG
Shaileshkumar Ghabhawala
Independent Non Exe. Director
Ind.
ZS
Zankhana Sheth
Independent Non Exe. Director
Ind.
MP
Mukesh Patel
Independent Non Exe. Director
Ind.
AJS
Alkesh Jayantilal Shah
Non-Exec & Non-Independent Dir
Ind.
Other Officials
SNS
Sharmin Nareshkumar Soni
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Bharat Parenterals Ltd? −

Bharat Parenterals Ltd trades on NSE under BPLPHARMA and on BSE under code 541096. The ISIN is INE365Y01019 and the face value is Rs 10.

What is the share price of Bharat Parenterals Ltd today? +

As of 27 September 2026, Bharat Parenterals Ltd trades at Rs 1,898.00, a change of 316.30 (20.00%) on the day. Prices are live and subject to change.

What is the market capitalisation of Bharat Parenterals Ltd? +

As of 27 September 2026, Bharat Parenterals Ltd has a market cap of about Rs 1306.1 crore. This figure is live and moves with the share price.

Is Bharat Parenterals Ltd profitable? +

In March 2026, Bharat Parenterals Ltd reported a profit after tax of Rs -8.19 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Bharat Parenterals Ltd? +

: As of 27 September 2026, the PE (TTM) for Bharat Parenterals Ltd is 134.98 and the price-to-book ratio is 3.25. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Bharat Parenterals Ltd pay a dividend? +

As of 27 September 2026, the dividend yield for Bharat Parenterals Ltd is 0.05%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Bharat Parenterals Ltd? +

As of the latest disclosed pattern, promoters hold 67.20% of Bharat Parenterals Ltd. Public shareholding is 32.80%, including mutual funds at 0.00% and foreign institutional investors at 0.11%.

What were the latest annual financials of Bharat Parenterals Ltd? +

In March 2026, Bharat Parenterals Ltd reported net sales of Rs 345.43 crore, revenue growth of 1.48%, and earnings per share of Rs -39.62.